Amarin News - AMRN

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Amarin Corp PLC AMRN NASDAQ Depository Receipt
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.06 0.37% 16.19 16.32 15.84 16.32 16.13 23:59:46
more quote information »

Recent News

Date Time Source Heading
10/21/20196:46IHNWFeaturedWhen it comes to championing older, established care homes, RB Care Homes are at the forefront of the advocacy.
10/21/201908:00IHNWOn Watch this Week with Near-Term Potential Catalysts
10/17/201909:49GLOBEIndependent Drug-Pricing Assessment Finds Vascepa®..
9/23/201916:15GLOBEAmarin to Participate in the Cantor Global Healthcare..
9/16/201906:00GLOBENational Lipid Association’s New Position Statement on Use..
9/12/201906:14EDGARCurrent Report Filing (8-k)
9/03/201906:00GLOBENew 2019 Updates to the European Society of Cardiology’s and..
8/28/201906:00GLOBEAmarin to Participate in the H.C. Wainwright 21st Annual..
8/27/201906:00GLOBEAmarin Provides Overview on Growing Global Attention on..
8/21/201906:00GLOBEAmarin to Participate in a Fireside Chat at Citi’s 14th..
8/09/201908:53PRNUSAmarin (AMRN) Alert: Johnson Fistel Launches Investigation..
8/09/201907:22EDGARCurrent Report Filing (8-k)
7/31/201906:34EDGARQuarterly Report (10-q)
7/31/201906:30EDGARCurrent Report Filing (8-k)
7/31/201905:00GLOBEAmarin Reports Second Quarter 2019 Financial Results and..
7/29/201917:17GLOBEAmarin Announces Underwriters’ Full Exercise of Option to..
7/24/201916:32EDGARCurrent Report Filing (8-k)
7/24/201906:00GLOBEAmarin to Report Second Quarter 2019 Results and Host..
7/19/201917:01EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
7/18/201923:47GLOBEAmarin Prices Public Offering of American Depositary Shares
7/17/201916:38EDGARCurrent Report Filing (8-k)
7/17/201916:02EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
7/17/201916:01GLOBEAmarin Announces $400,000,000 Public Offering of American..
7/15/201908:15IHNWBiotech Companies with Recent and Potential Near-Term..
7/02/201908:15EDGARCurrent Report Filing (8-k)
7/02/201906:00GLOBEAmarin Provides Mid-2019 Update, Including Commercialization..
6/21/201913:39GLOBEAmarin’s John Thero Awarded NJ EY Entrepreneur of The Year® ..
6/18/201907:00GLOBEAmarin to Present at the 2019 BMO Prescription For Success..
6/07/201910:55GLOBECORRECTING and REPLACING -- Amarin to Present Findings..
6/07/201907:12GLOBEAmarin to Present Findings Regarding Challenges of Current..
6/04/201906:00GLOBEAmarin to Present at the Goldman Sachs 40th Annual Global..
5/30/201907:00GLOBEPharmaceutical Industry Veteran Gwen Fisher Joins Amarin to..
5/30/201905:00GLOBEAmarin to Present at the Jefferies 2019 Healthcare..
5/29/201916:10EDGARCurrent Report Filing (8-k)
5/29/201906:00GLOBEU.S. FDA Grants Priority Review for Vascepa® (Icosapent..
5/23/201917:02EDGARCurrent Report Filing (8-k)
5/16/201916:15GLOBEVascepa® to Be Featured in Multiple Scientific Sessions at..
5/01/201906:50EDGARQuarterly Report (10-q)
5/01/201906:49EDGARCurrent Report Filing (8-k)
5/01/201905:00GLOBEAmarin Reports First Quarter 2019 Financial Results and..
4/29/201906:00GLOBENew Drug Submission Filed for Vascepa® with Health Canada
4/25/201907:02EDGARProxy Statement (definitive) (def 14a)
4/24/201906:00GLOBEAmarin To Report First Quarter 2019 Results and Host..
4/15/201917:08EDGARProxy Statement - Notice of Shareholders Meeting..
4/01/201917:09EDGARCurrent Report Filing (8-k)
3/29/201917:45GLOBEVascepa® Granted Priority Review Status from Health Canada
3/28/201916:51GLOBEAmarin Submits Supplemental New Drug Application (sNDA) to..
3/28/201905:00GLOBENew Updates to the American Diabetes Association’s® 2019..
3/19/201906:00GLOBECardiovascular Risk at Multiple Triglyceride Thresholds..
3/18/201916:15GLOBEAdditional Real-World Data Show a Significant Risk Increase..
3/18/201909:00PRNUSVascepa® (icosapent ethyl) Showed 30% Reduction in Total..
See more news about this stock »


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.